The American Journal of Surgery
Volume 193, Issue 1 , Pages 49-54, January 2007

Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study

  • Thomas E. Lyons, D.P.M.

      Affiliations

    • Beth Israel Deaconess Medical Center and Harvard Medical School, Palmer 321 A, West Campus, Boston, MA 02215, USA
    • ,
  • Michael S. Miller, D.O.

      Affiliations

    • The Wound Healing Center, Terre Haute, IN, USA
    • ,
  • Thomas Serena, M.D.

      Affiliations

    • Penn North Centers for Advanced Wound Care, Warren, PA, USA
    • ,
  • Peter Sheehan, M.D.

      Affiliations

    • New York University School of Medicine Hospital for Joint Diseases, New York, NY, USA
    • ,
  • Lawrence Lavery, D.P.M.

      Affiliations

    • Scott and White Hospital, Temple, TX, USA
    • ,
  • Robert S. Kirsner, M.D., Ph.D.

      Affiliations

    • University of Miami School of Medicine, Miami, FL, USA
    • ,
  • David G. Armstrong, D.P.M., Ph.D.

      Affiliations

    • Scholl’s Center for Lower Extremity Ambulatory Research at Rosalind Franklin University of Medicine and Science, Chicago, IL, USA
    • ,
  • Amber Reese, B.A.

      Affiliations

    • Agennix Inc, Houston, TX, USA
    • ,
  • Ernest W. Yankee, Ph.D.

      Affiliations

    • Agennix Inc, Houston, TX, USA
    • ,
  • Aristidis Veves, M.D., D.Sc.

      Affiliations

    • Beth Israel Deaconess Medical Center and Harvard Medical School, Palmer 321 A, West Campus, Boston, MA 02215, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-617-632-7075; fax: +1-617-632-7090.

Received 28 March 2006; received in revised form 23 July 2006 published online 10 November 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by Agennix, Inc. and the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institute of Health.David J. Margollis, M.D., Ph.D., served as the external NIH-approved Safety Officer.

PII: S0002-9610(06)00651-9

doi:10.1016/j.amjsurg.2006.07.010

The American Journal of Surgery
Volume 193, Issue 1 , Pages 49-54, January 2007

Article Tools

* Image Usage & Resolution